Nick Fuller
-
Clinical Trials Director, Department of Endocrinology, RPA Hospital,
University of Sydney
At the University of Sydney and Royal Prince Alfred Hospital, I am based at Charles Perkins Centre, a collaborative approach to the treatment of obesity and metabolic disease. Working with a broad client portfolio, my work focuses on the causes, prevention and treatment of obesity and metabolic disease. I have worked in both industry and academic appointments across a diverse range of areas, including dietary and exercise treatments, conventional and complementary medicines, commercial weight loss programmes, medical devices, bariatric surgery and appetite regulators. I am particularly passionate about translating science to the broader population and implementing a holistic approach for the treatment of overweight and obesity. More information on my translational work can be found at and My CV can be found at
Experience-
2007–present
Charles Perkins Centre Research Program Leader, The University of Sydney


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Ultrasound Devices Market Size Worth USD 887.0 Million By 2033 CAGR Of 5.4%
- Ecosync & Carboncore Launch Full Stages Refi Infrastructure Linking Carbon Credits With Web3
- Latin America Mobile Payment Market To Hit USD 1,688.0 Billion By 2033
- United States Lubricants Market Growth Opportunities & Share Dynamics 20252033
- Japan Smart Cities Market Size Is Expected To Reach USD 286.6 Billion By 2033 CAGR: 14.6%
- Blackrock Becomes The Second-Largest Shareholder Of Freedom Holding Corp.
Comments
No comment